Doctor profile · Federal record
Dr. Mohamed Aboyoussef, M.D.
Rheumatology Physician (CMS: Rheumatology) · Merritt Island, FL
- NPI 1972613057
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 30 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
Operates at 2 locations .
- Primary practice
-
40 Fortenberry RD
Merritt Island, FL 329523616
(321) 453-0779
fax (321) 453-4188 - Additional location
-
4332 S Hopkins Ave
Titusville, FL 327806610
(321) 264-1135
Credentials & registration
- NPI registered
- August 2006 — 20 yrs on file
- Profile last updated
- September 14, 2022
- Year of graduation
- 1996 — 30 yrs since
- Specialty taxonomy
- 207RR0500X — NUCC code
- State license (1)
- Florida #ME140157
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1972613057. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
440,472
Distinct HCPCS
10
Medicare allowed
$4,583,873
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0717 |
Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 262,000 | 103 | $5 | |
J3262 |
Injection, tocilizumab, 1 mg | 81,560 | 32 | $6 | |
J0129 |
Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 33,100 | 65 | $42 | |
J3111 |
Injection, romosozumab-aqqg, 1 mg | 28,360 | 28 | $10 | |
J1602 |
Injection, golimumab, 1 mg, for intravenous use | 13,930 | 20 | $13 | |
J0897 |
Injection, denosumab, 1 mg | 11,340 | 137 | $23 | |
J9312 |
Injection, rituximab, 10 mg | 2,370 | 12 | $80 | |
J1745 |
Injection, infliximab, excludes biosimilar, 10 mg | 2,070 | 13 | $33 | |
96401 |
Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 1,706 | 255 | $70 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 1,109 | 538 | $127 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 16,313. This provider delivers 27× the peer median.Open Payments
Industry payments received
All-time total
$1,723
Transactions
115
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Janssen Biotech, Inc. | 22 | $385.64 | |
| PFIZER INC. | 30 | $261.54 | |
| Amgen Inc. | 18 | $229.36 | |
| UCB, Inc. | 12 | $170.66 | |
| ABBVIE INC. | 8 | $137.57 | |
| SOBI, INC | 5 | $96.82 | |
| Novartis Pharmaceuticals Corporation | 4 | $94.65 | |
| Lilly USA, LLC | 3 | $67.90 | |
| GlaxoSmithKline, LLC. | 4 | $61.54 | |
| Organon Llc | 2 | $45.46 | |
| AstraZeneca Pharmaceuticals LP | 2 | $44.70 | |
| Genentech USA, Inc. | 2 | $43.98 | |
| Teva Pharmaceuticals USA, Inc. | 1 | $23.65 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $22.32 | |
| Radius Health, Inc. | 1 | $21.47 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
2,992
Patients
1,037
Total drug cost
$2,198,271
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Methotrexate (Methotrexate Sodium) | Brand | 687 | 243 | $26,938 |
| Hydroxychloroquine Sulfate | Generic | 631 | 219 | $49,934 |
| Prednisone | Generic | 621 | 197 | $6,871 |
| Allopurinol | Generic | 275 | 105 | $4,606 |
| Methylprednisolone | Generic | 153 | 111 | $1,996 |
| Folic Acid | Generic | 128 | 55 | $567 |
| Humira(Cf) Pen (Adalimumab) | Brand | 118 | 14 | $883,370 |
| Enbrel Sureclick (Etanercept) | Brand | 79 | 0 | $582,434 |
| Prolia (Denosumab) | Brand | 54 | 34 | $87,401 |
| Xeljanz Xr (Tofacitinib Citrate) | Brand | 51 | 0 | $297,992 |
Hospital affiliations
Frequently asked questions
What is Dr. Mohamed Aboyoussef's medical specialty?
Dr. Mohamed Aboyoussef practices Rheumatology Physician in Merritt Island, FL.
Where does Dr. Mohamed Aboyoussef practice?
Dr. Mohamed Aboyoussef practices at 40 Fortenberry RD, Merritt Island, FL 329523616. Office phone: 3214530779.
What is Dr. Mohamed Aboyoussef's NPI?
Dr. Mohamed Aboyoussef's National Provider Identifier (NPI) is 1972613057, issued by NPPES.
Does Dr. Mohamed Aboyoussef accept Medicare assignment?
Yes. Dr. Mohamed Aboyoussef accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Mohamed Aboyoussef commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, tocilizumab, 1 mg (HCPCS J3262); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129). Source: CMS Medicare Physician & Other Practitioners file.